Cancer (Oncology) Market Research Reports

Release Date: 1 to 2 years ago

Gastric Cancer? - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439519 | US$ 6,250.00 US$ 6,250.00
Thymus Cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439525 | US$ 6,250.00 US$ 6,250.00
Thyroid Cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439526 | US$ 6,250.00 US$ 6,250.00
Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439541 | US$ 6,250.00 US$ 6,250.00
AIDS Related Kaposi's Sarcoma - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439544 | US$ 6,250.00 US$ 6,250.00
Anal Cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439548 | US$ 6,250.00 US$ 6,250.00
Bladder cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439556 | US$ 6,250.00 US$ 6,250.00
Endometrial Cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439561 | US$ 6,250.00 US$ 6,250.00
Glioblastoma multiforme (GBM) - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439564 | US$ 6,250.00 US$ 6,250.00
Glioma - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439565 | US$ 6,250.00 US$ 6,250.00
Head and Neck cancer (HNC) - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439570 | US$ 6,250.00 US$ 6,250.00
Colorectal Cancer (CRC) - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439580 | US$ 6,250.00 US$ 6,250.00
Ewing Sarcoma - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439595 | US$ 6,250.00 US$ 6,250.00
Gallbladder Cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439597 | US$ 6,250.00 US$ 6,250.00
Hodgkin's lymphoma (HL) - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439602 | US$ 6,250.00 US$ 6,250.00
Larynx Cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439610 | US$ 6,250.00 US$ 6,250.00
Lip and Oral Cavity Cancer? - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439613 | US$ 6,250.00 US$ 6,250.00
Liver cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439614 | US$ 6,250.00 US$ 6,250.00
Multiple Myeloma - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439619 | US$ 6,250.00 US$ 6,250.00
Myelofibrosis (MF) - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439621 | US$ 6,250.00 US$ 6,250.00
Non-Hodgkin's Lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439622 | US$ 6,250.00 US$ 6,250.00
Oropharyngeal Cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439624 | US$ 6,250.00 US$ 6,250.00
Pancreatic Cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439628 | US$ 6,250.00 US$ 6,250.00
Neuroendocrine Carcinoma - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439630 | US$ 6,250.00 US$ 6,250.00
Prostate cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439632 | US$ 6,250.00 US$ 6,250.00
Renal cell carcinoma - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439634 | US$ 6,250.00 US$ 6,250.00
Small lymphocytic lymphoma - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439644 | US$ 6,250.00 US$ 6,250.00
Testicular cancer - Market Insight, Epidemiology and Market Forecast - 2027 Published: Jan 2018 | Pages: 100 | Report code: ASDR-439646 | US$ 6,250.00 US$ 6,250.00
Xtandi - API Insight,2018 Published: Jan 2018 | Pages: 30 | Report code: ASDR-439094 | US$ 500.00 US$ 500.00
Aplastic Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 60 | Report code: ASDR-439129 | US$ 2,000.00 US$ 2,000.00
B-Cell Chronic Lymphocytic Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 60 | Report code: ASDR-439135 | US$ 2,000.00 US$ 2,000.00
B-Cell Lymphomas - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 150 | Report code: ASDR-439136 | US$ 2,250.00 US$ 2,250.00
Biliary Tumor - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 60 | Report code: ASDR-439138 | US$ 2,000.00 US$ 2,000.00
Chemotherapy Induced Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 60 | Report code: ASDR-439140 | US$ 2,000.00 US$ 2,000.00
Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 60 | Report code: ASDR-439148 | US$ 2,000.00 US$ 2,000.00
Esophageal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 60 | Report code: ASDR-439150 | US$ 2,000.00 US$ 2,000.00
Hairy Cell Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 60 | Report code: ASDR-439156 | US$ 2,000.00 US$ 2,000.00
Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 60 | Report code: ASDR-439165 | US$ 2,000.00 US$ 2,000.00
Oral Mucositis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 40 | Report code: ASDR-439172 | US$ 1,500.00 US$ 1,500.00
Nasopharyngeal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Published: Jan 2018 | Pages: 40 | Report code: ASDR-439178 | US$ 1,500.00 US$ 1,500.00

Page 11 of 12 | < < first page | < previous 10 | 11 12 | last page > >

Select Category

Filter results

Cancer (Oncology) Market Research Reports